ConductScience.org, home

Paper · 6979751

Purification and initial characterization of rat interleukin 2.

Di Sabato G. Proc Natl Acad Sci U S A, 1982. Cited by 24 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Purification and initial characterization of rat interleukin 2. Papers, record 6979751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6979751

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Purification and initial characterization of rat interleukin 2.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
0.64
iCite
Revised in PubMed
2019-05-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Di Sabato GG

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interleukin-2Major topic
LymphokinesMajor topic
SpleenMajor topic
Animals
Chromatography
Isoelectric Point
Rats

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
CA-30172NCI NIH HHSUnited StatesR01CA030172PubMed and NIH

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,733,239The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.Biochem J1973https://conductscience.org/library/papers/4733239PubMed
21,092,483Production by murine spleen cells of an activity stimulating the PHA-responsiveness of thymus lymphocytes.Cell Immunol1975https://conductscience.org/library/papers/1092483PubMed
3132,275Further studies on the thymocyte stimulating factor.Cell Immunol1976https://conductscience.org/library/papers/132275PubMed
475,173Partial characterization and purification of murine T cell-replacing factor, TRF. II. Biochemical characteristics.Immunochemistry1978https://conductscience.org/library/papers/75173PubMed
5307,026Partial purification and molecular characterization of a lymphokine (costimulator) required for the mitogenic response of mouse thymocytes in vitro.J Immunol1978https://conductscience.org/library/papers/307026PubMed
6307,029T cell growth factor: parameters of production and a quantitative microassay for activity.J Immunol1978https://conductscience.org/library/papers/307029PubMed
7308,962Biochemical relationship of thymocyte mitogenic factor and factors enhancing humoral and cell-mediated immune responses.J Immunol1978https://conductscience.org/library/papers/308962PubMed
892,371Revised nomenclature for antigen-nonspecific T-cell proliferation and helper factors.Cell Immunol1979https://conductscience.org/library/papers/92371PubMed
9315,987Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines.J Exp Med1979https://conductscience.org/library/papers/315987PubMed
106,444,967Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.J Immunol1980https://conductscience.org/library/papers/6444967PubMed

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
6,608,103Purification to homogeneity and partial characterization of interleukin 2 from a human T-cell leukemia.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6608103PubMed
3,003,564Cloning and structure of a mouse interleukin-2 chromosomal gene.Mol Biol Rep1986https://conductscience.org/library/papers/3003564PubMed
2,958,404Mitogen-activated Xenopus laevis lymphocytes produce a T-cell growth factor.Immunology1987https://conductscience.org/library/papers/2958404PubMed
2,789,333Phosphorylation of human interleukin-2 (IL-2).Mol Cell Biochem1989https://conductscience.org/library/papers/2789333PubMed
2,312,156IL-2-like activity in lymph fluid following in vivo antigen challenge.Immunology1990https://conductscience.org/library/papers/2312156PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6979751

GET https://conductscience.org/api/papers/v1/6979751/authors